Andrew L. Ross - 17 Jun 2021 Form 4 Insider Report for iSpecimen Inc. (ISPC)

Role: Director, 10%+ Owner
Signature: /s/ Andrew L. Ross
Issuer symbol: ISPC
Transactions as of: 17 Jun 2021
Net transactions value: +$22,375
Form type: 4
Filing time: 29 Nov 2021, 19:01:04 UTC
Previous filing: 17 Jun 2021
Next filing: 23 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISPC	Common Stock	Purchase	$627	+100	+0.01%	$6.27^*	1,310,624	17 Jun 2021	Direct	F4
transaction	ISPC	Common Stock	Purchase	$2,608	+400	+0.03%	$6.52^*	1,311,024	23 Jun 2021	Direct
transaction	ISPC	Common Stock	Purchase	$5,730	+1,000	+0.08%	$5.73^*	1,312,024	08 Nov 2021	By Wingood Capital LLC
transaction	ISPC	Common Stock	Purchase	$2,925	+500	+0.04%	$5.85^*	1,312,524	10 Nov 2021	Direct
transaction	ISPC	Common Stock	Purchase	$2,645	+500	+0.04%	$5.29^*	1,313,024	15 Nov 2021	Direct
transaction	ISPC	Common Stock	Purchase	$2,650	+500	+0.04%	$5.30^*	1,313,524	15 Nov 2021	Direct
transaction	ISPC	Common Stock	Purchase	$5,190	+1,000	+0.08%	$5.19^*	1,314,524	16 Nov 2021	By Wingood Capital LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISPC	Non-Qualified Stock Options	Award		+13,525			13,525	30 Jul 2021	Common Stock	13,525		Direct	F1, F3
transaction	ISPC	Restricted Stock Units	Award		+2,500			2,500	30 Jul 2021	Common Stock	2,500		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each non-qualified stock option ("NSO") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such NSOs by iSpecimen Inc. (the "Company") to the Reporting Person pursuant to a Nonqualified Stock Option Award Agreement (the "NSO Agreement") under the iSpecimen Inc. 2021 Amended and Restated Stock Incentive Plan, as amended. The NSOs has a vesting term of three years with a one-year cliff (i.e. 33.33% of the NSOs vest on June 21, 2022, and the rest of the NSOs vest in equal quarterly installments on September 21, 2022 and each December 21, March 21, June 21 and September 21 until June 21, 2024), subject to the terms and conditions set forth in the NSO Agreement.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock at settlement subject to the terms and conditions set forth in the award of such RSUs by the Company to the Reporting Person pursuant to a Restricted Stock Unit Award Agreement (the "RSU Agreement"). The RSUs vest in four equal quarterly installments on September 21, 2021, December 21, 2021, March 21, 2022 and June 21, 2022, subject to the terms and conditions set forth in the RSU Agreement.
F3	The derivative securities were awarded as compensation to the Reporting Person for his service as the director of the Company.
F4	Including 1,310,524 shares of common stock acquired by the Reporting Person on June 21, 2021, as reported in the Form 4 filed with the Securities and Exchange Commission on June 23, 2021.